MedPath

Children's Oncology Group

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant

Phase 3
Completed
Conditions
Bacterial Infection
Methicillin-Resistant Staphylococcus Aureus Infection
Benign Neoplasm
Myeloid Neoplasm
Recurrent Childhood Acute Myeloid Leukemia
Malignant Neoplasm
Recurrent Childhood Acute Lymphoblastic Leukemia
Interventions
Procedure: Chlorhexidine Gluconate Skin Cleanser
Other: Laboratory Biomarker Analysis
Procedure: Mild Soap Skin Cleanser
Other: Questionnaire Administration
First Posted Date
2013-03-22
Last Posted Date
2021-06-22
Lead Sponsor
Children's Oncology Group
Target Recruit Count
177
Registration Number
NCT01817075
Locations
🇺🇸

Valley Children's Hospital, Madera, California, United States

🇺🇸

Children's Healthcare of Atlanta - Egleston, Atlanta, Georgia, United States

🇺🇸

Eastern Maine Medical Center, Bangor, Maine, United States

and more 56 locations

Gene Analysis in Studying Susceptibility to Wilms Tumor

Completed
Conditions
Stage II Kidney Wilms Tumor
Stage III Kidney Wilms Tumor
Stage IV Kidney Wilms Tumor
Recurrent Childhood Kidney Neoplasm
Stage I Kidney Wilms Tumor
Interventions
Other: Laboratory Biomarker Analysis
First Posted Date
2013-03-11
Last Posted Date
2016-08-22
Lead Sponsor
Children's Oncology Group
Target Recruit Count
1
Registration Number
NCT01808079
Locations
🇺🇸

Childrens Oncology Group, Philadelphia, Pennsylvania, United States

Genetic Biomarkers in Tissue Samples From Patients With Osteosarcoma

Completed
Conditions
Osteosarcoma
Interventions
Other: laboratory biomarker analysis
First Posted Date
2013-03-08
Last Posted Date
2016-03-08
Lead Sponsor
Children's Oncology Group
Target Recruit Count
10
Registration Number
NCT01807143
Locations
🇺🇸

Children's Oncology Group, Monrovia, California, United States

Biomarker Expression in Tissue Samples From Patients With Bone Sarcomas

Completed
Conditions
Localized Osteosarcoma
Metastatic Osteosarcoma
Recurrent Osteosarcoma
Interventions
Other: laboratory biomarker analysis
First Posted Date
2013-03-08
Last Posted Date
2016-05-19
Lead Sponsor
Children's Oncology Group
Target Recruit Count
34
Registration Number
NCT01807052
Locations
🇺🇸

Children's Oncology Group, Monrovia, California, United States

Biomarker Differences in Samples From Patients With Undifferentiated Sarcomas

Completed
Conditions
Soft Tissue Sarcoma
Interventions
Other: laboratory biomarker analysis
First Posted Date
2013-03-01
Last Posted Date
2016-07-14
Lead Sponsor
Children's Oncology Group
Target Recruit Count
49
Registration Number
NCT01802125
Locations
🇺🇸

Children's Oncology Group, Monrovia, California, United States

Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

Phase 1
Completed
Conditions
Stage 2B Neuroblastoma
Stage 4S Neuroblastoma
Stage 1 Neuroblastoma
Stage 4 Neuroblastoma
Stage 2 Neuroblastoma
Ganglioneuroblastoma
Stage 2A Neuroblastoma
Stage 3 Neuroblastoma
Interventions
Procedure: Autologous Hematopoietic Stem Cell Transplantation
Drug: Busulfan
Drug: Cisplatin
Drug: Cyclophosphamide
Drug: Doxorubicin Hydrochloride
Drug: Etoposide
Radiation: External Beam Radiation Therapy
Biological: Filgrastim
Other: Laboratory Biomarker Analysis
Drug: Melphalan
Drug: Mesna
Procedure: Peripheral Blood Stem Cell Transplantation
Other: Pharmacological Study
Drug: Topotecan Hydrochloride
Drug: Vincristine Sulfate
First Posted Date
2013-02-25
Last Posted Date
2024-07-15
Lead Sponsor
Children's Oncology Group
Target Recruit Count
150
Registration Number
NCT01798004
Locations
🇺🇸

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

🇨🇦

Hospital for Sick Children, Toronto, Ontario, Canada

🇺🇸

Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida, United States

and more 120 locations

Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas

Completed
Conditions
Burkitt Lymphoma
Hodgkin Lymphoma
Lymphoma
Anaplastic Large Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Interventions
Other: Laboratory Biomarker Analysis
Other: Questionnaire Administration
First Posted Date
2013-02-15
Last Posted Date
2024-08-26
Lead Sponsor
Children's Oncology Group
Target Recruit Count
203
Registration Number
NCT01793233
Locations
🇺🇸

Seattle Children's Hospital, Seattle, Washington, United States

🇺🇸

Methodist Children's Hospital of South Texas, San Antonio, Texas, United States

🇺🇸

University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

and more 104 locations

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Recruiting
Conditions
Osteosarcoma
Recurrent Leukemia
Lymphoblastic Lymphoma
Hodgkin Lymphoma in Remission
Leukemia in Remission
Recurrent Lymphoma
Recurrent Malignant Neoplasm
Interventions
Other: Assessment of Therapy Complications
Other: Laboratory Biomarker Analysis
Other: Quality-of-Life Assessment
Other: Questionnaire Administration
First Posted Date
2013-02-13
Last Posted Date
2024-04-17
Lead Sponsor
Children's Oncology Group
Target Recruit Count
420
Registration Number
NCT01790152
Locations
🇺🇸

Sinai Hospital of Baltimore, Baltimore, Maryland, United States

🇺🇸

Hurley Medical Center, Flint, Michigan, United States

🇺🇸

Columbia Regional, Columbia, Missouri, United States

and more 76 locations

Biomarkers in Patients With Advanced Rhabdomyosarcoma

Completed
Conditions
Childhood Embryonal Rhabdomyosarcoma
Recurrent Adult Soft Tissue Sarcoma
Stage III Adult Soft Tissue Sarcoma
Childhood Alveolar Rhabdomyosarcoma
Previously Treated Childhood Rhabdomyosarcoma
Recurrent Childhood Rhabdomyosarcoma
Stage IV Adult Soft Tissue Sarcoma
Adult Rhabdomyosarcoma
Interventions
Other: Laboratory Biomarker Analysis
First Posted Date
2012-08-17
Last Posted Date
2016-05-18
Lead Sponsor
Children's Oncology Group
Target Recruit Count
10
Registration Number
NCT01668095
Locations
🇺🇸

Children's Oncology Group, Philadelphia, Pennsylvania, United States

Studying Genes in Samples From Younger Patients With Acute Megakaryoblastic Leukemia

Completed
Conditions
Childhood Acute Megakaryocytic Leukemia (M7)
Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies
Interventions
Other: laboratory biomarker analysis
First Posted Date
2012-07-17
Last Posted Date
2016-05-18
Lead Sponsor
Children's Oncology Group
Target Recruit Count
100
Registration Number
NCT01642069
Locations
🇺🇸

Children's Oncology Group, Monrovia, California, United States

© Copyright 2025. All Rights Reserved by MedPath